Idexx Laboratories (IDXX) Depreciation & Amortization (CF) (2009 - 2026)

Idexx Laboratories (IDXX) has reported Depreciation & Amortization (CF) for 18 consecutive years, with $37.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 10.63% year-over-year to $37.7 million; the TTM figure through Mar 2026 stood at $148.8 million (up 10.97% YoY), while the FY2025 annual figure was $145.2 million, up 11.73% from the prior year.
• Depreciation & Amortization (CF) came in at $37.7 million for Q1 2026 at Idexx Laboratories, down from $38.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $38.7 million in Q4 2025, with the low at $26.5 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $31.7 million, with a median of $29.9 million recorded in 2024.
• Across the five-year window, Depreciation & Amortization (CF) dropped 0.95% in 2023 and climbed 17.76% in 2024, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $28.7 million in 2022, then grew by 3.54% to $29.7 million in 2023, then advanced by 13.35% to $33.7 million in 2024, then rose by 14.88% to $38.7 million in 2025, then slipped by 2.68% to $37.7 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $37.7 million, $38.7 million, and $36.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.